BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 567 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
1,551
1,497
1,727
2,010
2,120
1,257
Revenue Growth (YoY)
-20%
-13%
-14%
-5%
69%
202%
Cost of Revenue
998
716
805
1,017
1,031
688
Gross Profit
552
780
922
993
1,089
569
Selling, General & Admin
409
714
739
831
1,162
669
Research & Development
103
119
131
227
--
--
Operating Expenses
803
1,030
1,216
1,112
1,364
806
Other Non Operating Income (Expenses)
--
--
0
-3
-10
-5
Pretax Income
-1,578
-1,577
-81
-797
-34
-213
Income Tax Expense
4
6
28
-8
53
15
Net Income
-1,088
-1,088
-5
-1,172
-832
-227
Net Income Growth
21,660%
21,660%
-100%
41%
267%
373%
Shares Outstanding (Diluted)
70.57
70.57
70.57
70.57
64.34
57.26
Shares Change (YoY)
0%
0%
0%
10%
12%
31%
EPS (Diluted)
-15.42
-15.42
-0.07
-16.61
-12.94
-3.97
EPS Growth
21,929%
21,929%
-100%
28%
225.99%
262%
Free Cash Flow
43
43
72
-112
-799
-676
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
35.58%
52.1%
53.38%
49.4%
51.36%
45.26%
Operating Margin
-16.11%
-16.63%
-17.02%
-5.92%
-12.92%
-18.77%
Profit Margin
-70.14%
-72.67%
-0.28%
-58.3%
-39.24%
-18.05%
Free Cash Flow Margin
2.77%
2.87%
4.16%
-5.57%
-37.68%
-53.77%
EBITDA
1,021
1,022
184
1,810
666
-45
EBITDA Margin
65.82%
68.26%
10.65%
90.04%
31.41%
-3.57%
D&A For EBITDA
1,271
1,271
478
1,929
940
191
EBIT
-250
-249
-294
-119
-274
-236
EBIT Margin
-16.11%
-16.63%
-17.02%
-5.92%
-12.92%
-18.77%
Effective Tax Rate
-0.25%
-0.38%
-34.56%
1%
-155.88%
-7.04%
Follow-Up Questions
What are BICO Group AB's key financial statements?
According to the latest financial statement (Form-10K), BICO Group AB has a total asset of $3,696, Net loss of $-1,088
What are the key financial ratios for CLLKF?
BICO Group AB's Current ratio is 1.89, has a Net margin is -72.67, sales per share of $21.21.
How is BICO Group AB's revenue broken down by segment or geography?
BICO Group AB largest revenue segment is Life Science Solutions, at a revenue of 1,009,100,000 in the most earnings release.For geography, United States is the primary market for BICO Group AB, at a revenue of 1,162,800,000.
Is BICO Group AB profitable?
no, according to the latest financial statements, BICO Group AB has a net loss of $-1,088
Does BICO Group AB have any liabilities?
yes, BICO Group AB has liability of 1,948
How many outstanding shares for BICO Group AB?
BICO Group AB has a total outstanding shares of 70.57